Epidemiology of bacterial infections. Investigation of the pathogenesis and molecular basis of antimicrobial resistance
PRINCIPAL INVESTIGATORS
- Maria Carmen Ardanuy Tisaire
- Laura Calatayud Samper
- Jordi Camara Mas
- Immaculada Grau Garriga
- Román Pallarés Giner
- Miquel Pujol Rojo
- Teresa Vinuesa Aumedes
- Miquel Viñas Ciordia
CLINICAL RESEARCHERS
- Claudia Arajol González
- Dàmaris Berbel Palau
- María Bonilla Moreno
- Rosa Maria Costa Primo
- Lucía Fernández Delgado
- Manuel Gonzalez De Aledo Fernandez
- Guillem López De Egea Vera
- Catalina Medina Gomez
- Maria Clara Moreto Castellsague
- Nuria Prim Bosch
- David Sanchez Ramos
POSTDOCTORAL RESEARCHERS
- Paula Andrea Espinal Marin
- Ester Fusté Domínguez
- Aida González Díaz
- Marta Jorba Pedrosa
- Eulalia Sans Serramitjana
- Josep Maria Sierra Ortigosa
PREDOCTORAL RESEARCHERS
- Irene Cadenas Jimenez
- Sara Calvo Silveria
- Rocio España Bonilla
- Daiana Solange Guevara Nuñez
- Anna Lien Ferrero
- Lucia Saiz Escobedo
Translational Medicine
Infectious disease and transplantation
Scientific production
50
PAPERS
Average IF: 4,36
25
LED PAPERS
Average IF: 3,90
8 PUBLICATIONS IN FIRST DECILE
28 PUBLICATIONS IN FIRST QUARTILE
34 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Ardanuy,C;Càmara,J, Hidden risks: long-term mortality after invasive pneumococcal disease., Lancet Health. Longev., 2025;6(11):100785-100785, doi:10.1016/j.lanhl.2025.100785
- Peñalva,G;Cantón,R;Pérez Rodríguez,MT;González López,JJ;Rodríguez Baño,J;Barrio Tofiño,ED;Kirkegaard Biosca,C et al, Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studies., Lancet Reg Health Eur, 2025;51101220-101220, doi:10.1016/j.lanepe.2025.101220
- Gonzalez Sanchez,A;Andres,C;Prats Mendez,I;Piñana,M;Coma,E;Bernet,A;Casan,C et al, Evolutionary dynamics of HRSV following the implementation of nirsevimab immunoprophylaxis in Catalonia (2023-2024), J Infect, 2025;91(3):106567-106567, doi:10.1016/j.jinf.2025.106567
- Lapeña,P;Urra,X;Llopis,J;Hernández Meneses,M;Cuervo,G;Maisterra,O;Escrihuela Vidal,F et al, Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis., Clin Microbiol Infect, 2025;31(8):1321-1329, doi:10.1016/j.cmi.2025.02.008
- Pérez García,C;González Díaz,A;Domenech,M;Llamosí,M;Úbeda,A;Sanz,JC;García,E et al, The rise of serotype 8 is associated with lineages and mutations in the capsular operon with different potential to produce invasive pneumococcal disease., Emerg Microbes Infect, 2025;14(1):2521845-2521845, doi:10.1080/22221751.2025.2521845
Research highlights
PROJECTS
1 Granted competitive project
10 Ongoing competitive projects
4 Started clinical trials
9 Ongoing clinical trials
NETWORKS
CIBERES
CIBERINFEC
Selected projects
- 2023-507293-40-00. A PHASE 4 STUDY USING A TEST-NEGATIVE DESIGN TO EVALUATE THE EFFECTIVENESS OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS ≥65 YEARS OF AGE. Pfizer Inc. Budget: 162.540€. 2024- . PI: MARIA CARMEN ARDANUY TISAIRE.
- PI21/01000. Una perspectiva global de las enfermedades neumocócicas y la resistencia en tiempos de pandemia por COVID-19 y vacunación universal en pediatría. Instituto de Salud Carlos III (ISCIII). Budget: 91.960€. 2022-2025. PI: ARDANUY TISAIRE, MARIA CARMEN.
- CP19/00096. CONTRATOS MIGUEL SERVET – ISCIII. Instituto de Salud Carlos III (ISCIII). Budget: 130.155,12€. 2024-2025. PI: MARTI MARTI, SARA.
- PI24/01378. Explorando la colonización y los serotipos de Streptococcus pneumoniae en adultos de riesgo: Implicaciones para la vacunación. Instituto de Salud Carlos III (ISCIII). Budget: 70.000€. 2025-2027. PI: CAMARA MAS, JORDI.
- 101113109. RELECOV 2.0: Consolidation of WGS and RT-PCR activities for SARS-CoV-2 in Spain towards sustainable use and integration of enhanced infrastructure and capacities in the RELECOV network (101113109). COMISSIÓ EUROPEA. Budget: 26.405,12€. 2023-2028. PI: DOMINGUEZ LUZON, MARIA ANGELES.